ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
Q4 2024 vs. Q3 2024
How the institutions holding ESSA Pharma Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 32 | 45 | +13 |
| Shares | 35.1M | 32.8M | −2.27M (−6.5%) |
| Value | $212.7M | $58.8M | −$154.0M (−72.4%) |
New holders (23)
Institutions that held ESSA Pharma Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (10)
Institutions that held ESSA Pharma Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Bellevue Group AG | 7,879,583 | $47.8M |
| PFM Health Sciences, LP | 2,742,936 | $16.6M |
| Adage Capital Partners GP, L.L.C. | 1,474,165 | $8.93M |
| Rhenman & Partners Asset Management AB | 804,649 | $4.88M |
| Rock Springs Capital Management LP | 677,005 | $4.10M |
| Parkman Healthcare Partners LLC | 345,902 | $2.10M |
| CIBC World Markets Inc. | 73,587 | $446.0K |
| D. E. Shaw & Co., Inc. | 62,955 | $381.5K |
| Kennedy Capital Management, Inc. | 41,092 | $249.0K |
| Simplex Trading, LLC | 5,162 | $31.0K |